Skip to main content
Download PDF
- Main
Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective
- Flaherty, Keith T;
- Doroshow, James H;
- Galbraith, Susan;
- Ribas, Antoni;
- Kluetz, Paul G;
- Pazdur, Richard;
- Theoret, Marc R
Published Web Location
https://doi.org/10.1158/2159-8290.cd-21-0850Abstract
The COVID-19 pandemic brought about major changes in cancer clinical trials. In its aftermath, the community has an opportunity to incorporate some of these changes as part of the future of trial conduct to make it more patient centered.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.